Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05671055 · ClinicalTrials.gov registry record

CogMS - A Real-world Study Into Cognitive Impairment in People With Multiple Sclerosis

A clinical trial of Multiple Sclerosis, sponsored by icometrix.

Completed
Registry status
300
Enrollment target
10
Study locations

NCT05671055 is a study of Multiple Sclerosis that has completed, run by icometrix. The registered enrollment target is 300 participants, below the 584-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (49% lower). The trial reports 10 study locations across 5 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05671055, a study of Multiple Sclerosis, has completed, sponsored by icometrix.

COMPLETED
Registry status
300 participants
Enrollment target
10
Study locations

Study Summary

The present study will investigate the correlation between objective and subjective cognition in multiple sclerosis. The study will also investigate the impact of covariates such as fatigue and depression, the relationship with the Expanded Disability Status Scale (EDSS) and brain volumetrics as measured on magnetic resonance imaging (MRI). Additionally, the study will provide insights into patients' experiences with cognition, and the usability of the used objective cognitive assessments.

Conditions Studied

Multiple Sclerosis

Interventions

  • OTHER Custom study version of icompanion app

Study Locations (10)

Other

  • GZA Antwerpen - Antwerp
  • Imelda Ziekenhuis - Bonheiden
  • AZ Sint-Jan Brugge - Bruges
  • UZ Brussel - Jette
  • University of Greifswald - Greifswald

Colorado

  • UCHealth - Aurora
  • Brain Health Center of the Rockies - Fort Collins

New York

  • Dent Neurologic Institute - Buffalo

Ohio

  • The Boster Center for Multiple Sclerosis - Columbus

Texas

  • Texas Neurology - Dallas

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2023-01-07
Est. Completion 2023-12-06

Sponsor

icometrix

1 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05671055

The ClinicalTrials.gov registry entry for NCT05671055 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 584-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (49% lower). The listed sponsor is icometrix, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Multiple Sclerosis appearing as the primary indexed condition, and to 1 intervention - of which Custom study version of icompanion app is the first listed.

NCT05671055 reports 10 study locations spanning 5 distinct geographic areas - top geographies include Other, Colorado, New York.

Frequently Asked Questions

What is clinical trial NCT05671055 about?

NCT05671055 is a clinical study titled "CogMS - A Real-world Study Into Cognitive Impairment in People With Multiple Sclerosis". The present study will investigate the correlation between objective and subjective cognition in multiple sclerosis. The study will also investigate the impact of covariates such as fatigue and depression, the relationship with the Expanded Disability Status Scale (EDSS) and brain volumetrics as mea...

What is the current status of trial NCT05671055?

This trial is currently completed. The enrollment target is 300 participants. The study started on 2023-01-07. Estimated completion is 2023-12-06.

What conditions does trial NCT05671055 study?

This clinical trial studies the following conditions: Multiple Sclerosis.

What interventions are being tested in trial NCT05671055?

The interventions under investigation include: Custom study version of icompanion app (OTHER).

Who is sponsoring clinical trial NCT05671055?

This trial is sponsored by icometrix, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05671055 being conducted?

This trial has 10 study locations across Colorado, New York, Ohio, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Multiple Sclerosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Multiple Sclerosis

All registered trials for this condition

Colorado

All trials with a study site in Colorado

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.